Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 3
1994 3
1996 2
1997 2
1998 3
1999 3
2000 3
2001 3
2002 1
2003 2
2004 2
2005 4
2006 3
2007 3
2008 3
2009 7
2010 6
2011 5
2012 9
2013 4
2014 5
2015 9
2016 8
2017 7
2018 6
2019 8
2020 8
2021 9
2022 2
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
[Next generation of anti-immune checkpoints antibodies].
Bonnefoy N, Olive D, Vanhove B. Bonnefoy N, et al. Among authors: vanhove b. Med Sci (Paris). 2019 Dec;35(12):966-974. doi: 10.1051/medsci/2019193. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903901 Free article. Review. French.
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation.
Segovia M, Russo S, Jeldres M, Mahmoud YD, Perez V, Duhalde M, Charnet P, Rousset M, Victoria S, Veigas F, Louvet C, Vanhove B, Floto RA, Anegon I, Cuturi MC, Girotti MR, Rabinovich GA, Hill M. Segovia M, et al. Among authors: vanhove b. Cancer Cell. 2019 May 13;35(5):767-781.e6. doi: 10.1016/j.ccell.2019.04.003. Cancer Cell. 2019. PMID: 31085177 Free PMC article.
Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders.
Vanhove B, Poirier N, Fakhouri F, Laurent L, 't Hart B, Papotto PH, Rizzo LV, Zaitsu M, Issa F, Wood K, Soulillou JP, Blancho G. Vanhove B, et al. Antibodies (Basel). 2017 Nov 21;6(4):19. doi: 10.3390/antib6040019. Antibodies (Basel). 2017. PMID: 31548534 Free PMC article. Review.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Gaborit B, et al. Among authors: vanhove b. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad525. doi: 10.1093/ofid/ofad525. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37942459 Free PMC article.
[Monoclonal antibodies in organ transplantation].
Vanhove B. Vanhove B. Med Sci (Paris). 2009 Dec;25(12):1121-5. doi: 10.1051/medsci/200925121121. Med Sci (Paris). 2009. PMID: 20035690 Free article. Review. French.
Depleting T-cell subpopulations in organ transplantation.
Haudebourg T, Poirier N, Vanhove B. Haudebourg T, et al. Among authors: vanhove b. Transpl Int. 2009 May;22(5):509-18. doi: 10.1111/j.1432-2277.2008.00788.x. Epub 2008 Oct 30. Transpl Int. 2009. PMID: 18980625 Free article. Review.
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19.
Poulakou G, Royer PJ, Evgeniev N, Evanno G, Shneiker F, Marcelin AG, Vanhove B, Duvaux O, Marot S, Calvez V. Poulakou G, et al. Among authors: vanhove b. Front Immunol. 2024 Apr 17;15:1330178. doi: 10.3389/fimmu.2024.1330178. eCollection 2024. Front Immunol. 2024. PMID: 38694503 Free PMC article. Clinical Trial.
127 results